Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support
- PMID: 30121090
- PMCID: PMC6098836
- DOI: 10.1186/s13054-018-2081-2
Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support
Abstract
Background: Microcirculatory dysfunction develops in both septic and cardiogenic shock patients, and it is associated with poor prognosis in patients with septic shock. Information on the association between microcirculatory dysfunction and prognosis in cardiogenic shock patients with venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is limited.
Methods: Sublingual microcirculation images were recorded using an incident dark-field video microscope at the following time points: within 12 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), and 96 h (T5) after VA-ECMO placement. If a patient could be weaned off VA-ECMO, sublingual microcirculation images were recorded before and after VA-ECMO removal. Microcirculatory parameters were compared between 28-day nonsurvivors and survivors with VA-ECMO support. In addition, the microcirculation and clinical parameters were assessed as prognostic tests of 28-day mortality, and patients were divided into three subgroups according to microcirculation parameters for survival analysis.
Results: Forty-eight patients were enrolled in this study. At T1, the observed heart rate, mean arterial pressure, inotropic score and lactate level of 28-day nonsurvivors and survivors did not differ significantly, but the perfused small vessel density (PSVD) and proportion of perfused vessels (PPV) were lower in the 28-day nonsurvivors than in the survivors. The PSVD and PPV were slightly superior to lactate levels in predicting 28-day mortality (area under curve of 0.68, 0.70, and 0.62, respectively). The subgroup with the lowest PSVD (< 15 mm/mm2) and PPV (< 64%) values exhibited less favorable survival compared with the other two subgroups.
Conclusions: Early microcirculatory parameters could be used to predict the survival of cardiogenic shock patients with VA-ECMO support.
Trial registration: ClinicalTrials.gov, NCT02393274 . Registered on 19 March 2015.
Keywords: Cardiogenic shock; Extracorporeal membrane oxygenation; Microcirculation; Survival.
Conflict of interest statement
Ethics approval and consent to participate
This prospective observational study was approved by the Research Ethics Committee of National Taiwan University Hospital (approval number 201412045RINA).
Consent for publication
Informed consent of the patients was obtained from their legally authorized representatives before enrollment in the study.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Comment in
-
Microcirculation in cardiogenic shock supported with extracorporeal membrane oxygenation: the need for a homogeneous population and strict evolution assessment.Crit Care. 2018 Oct 29;22(1):281. doi: 10.1186/s13054-018-2214-7. Crit Care. 2018. PMID: 30373656 Free PMC article. No abstract available.
References
-
- Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Diebold B, Chastre J, Combes A. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011;37(11):1738–1745. doi: 10.1007/s00134-011-2358-2. - DOI - PubMed
-
- Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC, Chi NH, Wang CH, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554–561. doi: 10.1016/S0140-6736(08)60958-7. - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
